CLDN9 and endometrial cancer: CLDN9 has been found to be related to many human malignancies, such as non-Hodgkin's lymphoma, breast cancer, pituitary oncocytomas, laryngeal carcinoma and endometrial cancer, contributing to disease progression and poor prognosis in patients.